ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cannara Biotech, Inc. ?
1
With ROE of -10.12%, it has a very attractive valuation with a 1.58 Price to Book Value
- Over the past year, while the stock has generated a return of 36.96%, its profits have risen by 44.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cannara Biotech, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Cannara Biotech, Inc.
36.96%
3.60
46.17%
S&P/TSX 60
23.72%
1.94
15.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
101.41%
EBIT Growth (5y)
5.12%
EBIT to Interest (avg)
-2.93
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
0.63
Tax Ratio
1.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.23%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.58
EV to EBIT
-19.68
EV to EBITDA
-56.04
EV to Capital Employed
1.44
EV to Sales
1.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.30%
ROE (Latest)
-10.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD 19 MM
NET PROFIT(HY)
Higher at CAD -3.93 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 16.44 %
NET SALES(Q)
Highest at CAD 30.11 MM
RAW MATERIAL COST(Y)
Fallen by -45.82% (YoY
CASH AND EQV(HY)
Highest at CAD 30.88 MM
-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 2 times
EPS(Q)
Lowest at CAD 0.01
Here's what is working for Cannara Biotech, Inc.
Operating Cash Flow
Highest at CAD 19 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Net Sales
Highest at CAD 30.11 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (CAD MM)
Net Profit
Higher at CAD -3.93 MM
than preceding 12 month period ended Nov 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CAD MM)
Debt-Equity Ratio
Lowest at 16.44 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Cash and Eqv
Highest at CAD 30.88 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -45.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cannara Biotech, Inc.
EPS
Lowest at CAD 0.01
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CAD)
Inventory Turnover Ratio
Lowest at 2 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
